Odiparcil

DRUG3 trials

Sponsors

GlaxoSmithKline, Inventiva Pharma

Conditions

Atrial FibrillationDeep Vein ThrombosisFibrillation, AtrialMucopolysaccharidosis VIPulmonary EmbolismVenous Thromboembolism

Phase 1

Odiparcil QT Definitive Study

TerminatedNCT00437242

GlaxoSmithKlineAtrial Fibrillation, Fibrillation, Atrial

Start: 2006-10-31Target: 54Updated: 2012-06-04

Phase 2

Odiparcil For The Prevention Of Venous Thromboembolism

CompletedNCT00244725

GlaxoSmithKlineDeep Vein Thrombosis, Fibrillation, Atrial, Pulmonary Embolism +1

Start: 2005-09-30End: 2006-09-30Updated: 2017-05-02

A Study in MPS VI to Assess Safety and Efficacy of Odiparcil

CompletedNCT03370653

Inventiva PharmaMucopolysaccharidosis VI

Start: 2017-12-30End: 2019-10-22Updated: 2019-11-01